2-(Hex-5-yn-1-yl)isoindoline-1,3-dione

Catalog No. :
ACYBIK718
CAS No. :
6097-08-1
Molecular Formula :
C14H13NO2
Molecular Weight :
227.26

IUPAC Name:2-(hex-5-yn-1-yl)isoindoline-1,3-dione

2-(Hex-5-yn-1-yl)isoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$100.00Login to see priceIn stockIn stock
25g97%$407.00Login to see priceInquiryIn stock
100g97%$1259.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Hex-5-yn-1-yl)isoindoline-1,3-dione
IUPAC Name2-(hex-5-yn-1-yl)isoindoline-1,3-dione
MDL No.0
Molecular FormulaC14H13NO2
Molecular Weight227.26
SMILESO=C1N(CCCCC#C)C(C2=C1C=CC=C2)=O
InChI KeyWALVSJIWVWDFCU-UHFFFAOYSA-N
SynonymAS-63685 | SB64807 | 6-Phthalimido-1-hexyne | WALVSJIWVWDFCU-UHFFFAOYSA-N | N-(5-Hexynyl)phthalimide | AKOS015898135 | SCHEMBL504643 | MFCD00671372 | N-(5-Hexynyl)phthalimide, >=95% | 2-hex-5-ynylisoindole-1,3-dione | CS-0036692 | W11375 | 2-(hex-5-yn-1-y
CAS No.6097-08-1
PubChem CID3346053

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H317
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACYBIK718 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMWKI059 route compound structure diagram
    ACMWKI059928-90-5 In Stock
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACYBIK718 route product structure diagram
    ACYBIK7186097-08-1 In Stock
Inquiry

2. ACYBIK718 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRFQE813 route compound structure diagram
    ACRFQE81366977-99-9 In Stock
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACYBIK718 route product structure diagram
    ACYBIK7186097-08-1 In Stock
Inquiry

Comments (0)